Jiang G et al. |
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation. |
2015 |
PLoS Pathog. |
pmid:26225771
|
Freiberger SN et al. |
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2. |
2015 |
Mol. Cancer Ther. |
pmid:26116359
|
Soini EJ et al. |
Cost-utility of first-line actinic keratosis treatments in Finland. |
2015 |
Adv Ther |
pmid:26006101
|
Cantisani C et al. |
Evaluation of Ingenol mebutate efficacy for the treatment of actinic keratosis with Antera 3D camera. |
2015 |
Eur Rev Med Pharmacol Sci |
pmid:25635981
|
Edwards SK et al. |
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma. |
2013 |
BMC Cancer |
pmid:24131623
|
Song X et al. |
RasGRPs are targets of the anti-cancer agent ingenol-3-angelate. |
2013 |
PLoS ONE |
pmid:23991094
|
Cozzi SJ et al. |
Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. |
2013 |
Arch. Dermatol. Res. |
pmid:22871992
|
Liang X et al. |
Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer. |
2013 |
Bioorg. Med. Chem. Lett. |
pmid:23993332
|
Doan HQ et al. |
Ingenol mebutate: potential for further development of cancer immunotherapy. |
2012 |
J Drugs Dermatol |
pmid:23134979
|
Lebwohl M et al. |
Ingenol mebutate gel for actinic keratosis. |
2012 |
N. Engl. J. Med. |
pmid:22417254
|